nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced imaging tools for childhood tuberculosis: potential applications and research needs
|
Jain, Sanjay K |
|
|
20 |
11 |
p. e289-e297 |
artikel |
2 |
Aqueous olanexidine versus aqueous povidone-iodine for surgical skin antisepsis on the incidence of surgical site infections after clean-contaminated surgery: a multicentre, prospective, blinded-endpoint, randomised controlled trial
|
Obara, Hideaki |
|
|
20 |
11 |
p. 1281-1289 |
artikel |
3 |
Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study
|
Badr, Hamada S |
|
|
20 |
11 |
p. 1247-1254 |
artikel |
4 |
Association of mediastinal lymphadenopathy with COVID-19 prognosis
|
Sardanelli, Francesco |
|
|
20 |
11 |
p. 1230-1231 |
artikel |
5 |
Burden of disease in Gabon caused by loiasis: a cross-sectional survey
|
Veletzky, Luzia |
|
|
20 |
11 |
p. 1339-1346 |
artikel |
6 |
Challenges and issues of SARS-CoV-2 pool testing
|
Mishra, Baijayantimala |
|
|
20 |
11 |
p. 1233 |
artikel |
7 |
Challenges and issues of SARS-CoV-2 pool testing
|
Eberhardt, Jens N |
|
|
20 |
11 |
p. 1233-1234 |
artikel |
8 |
Challenges and issues of SARS-CoV-2 pool testing
|
Lee, Jaehyeon |
|
|
20 |
11 |
p. 1232-1233 |
artikel |
9 |
Challenges and issues of SARS-CoV-2 pool testing – Authors' reply
|
Lohse, Stefan |
|
|
20 |
11 |
p. 1234-1235 |
artikel |
10 |
Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies
|
Gumisiriza, Nolbert |
|
|
20 |
11 |
p. 1315-1323 |
artikel |
11 |
China's successful control of COVID-19
|
Burki, Talha |
|
|
20 |
11 |
p. 1240-1241 |
artikel |
12 |
Clinical and epidemiological performance of WHO Ebola case definitions: a systematic review and meta-analysis
|
Caleo, Grazia |
|
|
20 |
11 |
p. 1324-1338 |
artikel |
13 |
Clinical variables and gene signatures in tuberculosis
|
Acuña-Villaorduña, Carlos |
|
|
20 |
11 |
p. 1227-1229 |
artikel |
14 |
Correction to Lancet Infect Dis 2020; published online Aug 25. https://doi.org/10.1016/S1473-3099(20)30577-6
|
|
|
|
20 |
11 |
p. e275 |
artikel |
15 |
Correction to Lancet Infect Dis 2020; published online Aug 25. https://doi.org/10.1016/S1473-3099(20)30289-9
|
|
|
|
20 |
11 |
p. e275 |
artikel |
16 |
COVID-19 and multisystem inflammatory syndrome in children and adolescents
|
Jiang, Li |
|
|
20 |
11 |
p. e276-e288 |
artikel |
17 |
COVID-19: from rapid genome sequencing to fast decisions
|
Behrmann, Ole |
|
|
20 |
11 |
p. 1218 |
artikel |
18 |
COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study
|
Sikkema, Reina S |
|
|
20 |
11 |
p. 1273-1280 |
artikel |
19 |
Emerging macrolide resistance in Mycoplasma genitalium
|
Cools, Piet |
|
|
20 |
11 |
p. 1222-1223 |
artikel |
20 |
Evaluating case definitions for Ebola virus disease
|
Ramharter, Michael |
|
|
20 |
11 |
p. 1224-1226 |
artikel |
21 |
Infectious disease surveillance update
|
Zwizwai, Ruth |
|
|
20 |
11 |
p. 1241 |
artikel |
22 |
Macrolide consumption and resistance in Mycoplasma genitalium
|
Kenyon, Chris |
|
|
20 |
11 |
p. 1235-1236 |
artikel |
23 |
Matshidiso Moeti, first female WHO Regional Director
|
Kirby, Tony |
|
|
20 |
11 |
p. 1244 |
artikel |
24 |
Mediastinal lymphadenopathy in patients with severe COVID-19
|
Valette, Xavier |
|
|
20 |
11 |
p. 1230 |
artikel |
25 |
New guidelines to treat bacterial infections
|
Mushtaq, Ammara |
|
|
20 |
11 |
p. 1239 |
artikel |
26 |
Novel evidence to motivate onchocerciasis elimination
|
Romo, Matthew L |
|
|
20 |
11 |
p. 1223-1224 |
artikel |
27 |
Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis
|
Dawood, Fatimah S |
|
|
20 |
11 |
p. 1255-1262 |
artikel |
28 |
Peter Byass
|
Kazi, Farooq |
|
|
20 |
11 |
p. 1243 |
artikel |
29 |
Pooling of samples for testing for SARS-CoV-2 in asymptomatic people
|
Lohse, Stefan |
|
|
20 |
11 |
p. 1231-1232 |
artikel |
30 |
Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis
|
Machalek, Dorothy A |
|
|
20 |
11 |
p. 1302-1314 |
artikel |
31 |
Pulmonary embolism associated with mycoplasma in a child
|
Chen, Shanjia |
|
|
20 |
11 |
p. 1347 |
artikel |
32 |
Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study
|
Meredith, Luke W |
|
|
20 |
11 |
p. 1263-1271 |
artikel |
33 |
Research in brief
|
Devi, Sharmila |
|
|
20 |
11 |
p. 1242 |
artikel |
34 |
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study
|
Jahnmatz, Maja |
|
|
20 |
11 |
p. 1290-1301 |
artikel |
35 |
Should olanexidine be used routinely for surgical skin antisepsis?
|
Willy, Christian |
|
|
20 |
11 |
p. 1219-1220 |
artikel |
36 |
Streptococcal toxic shock syndrome revealed phlegmasia cerulea dolens of the arm
|
Moris, Vivien |
|
|
20 |
11 |
p. 1348 |
artikel |
37 |
Taking science talks online
|
Ranscombe, Peter |
|
|
20 |
11 |
p. 1246 |
artikel |
38 |
The intersection of COVID-19 and mental health
|
The Lancet Infectious Diseases, |
|
|
20 |
11 |
p. 1217 |
artikel |
39 |
The mother of invention
|
Stirrups, Robert |
|
|
20 |
11 |
p. 1245 |
artikel |
40 |
The potential for improved protection against pertussis
|
Marshall, Helen S |
|
|
20 |
11 |
p. 1220-1222 |
artikel |
41 |
The 11th annual NTD NGO Network conference
|
Jesudason, Timothy |
|
|
20 |
11 |
p. 1238 |
artikel |
42 |
Uncovering the burden of loiasis: first estimates from Gabon
|
Pion, Sébastien D |
|
|
20 |
11 |
p. 1226-1227 |
artikel |
43 |
Why we should stop using the word leprosy
|
Barve, Ajit |
|
|
20 |
11 |
p. 1236-1237 |
artikel |
44 |
Why we should stop using the word leprosy
|
Deps, Patrícia D |
|
|
20 |
11 |
p. 1236 |
artikel |